Form 4: Onconetix Director Thomas Meier Acquires Shares Through Restricted Stock Award

Director Thomas Meier acquired 3,318 shares of Onconetix, Inc. common stock through a restricted stock award.

Summary

• On September 26, 2024, Thomas Meier, a director of Onconetix, Inc., acquired 3,318 shares of common stock.
• The acquisition was a result of a restricted stock award granted under the Issuer's 2022 Equity Incentive Plan, as amended.
• The shares were acquired at a price of $0.
• The award will vest in full on August 31, 2025, contingent upon Meier's continued service as a non-employee director until that date.
• Following the transaction, Meier directly owns 3,318 shares of Onconetix common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of a stock award, which is neither particularly positive nor negative.

Positives

• The acquisition of shares by a director signals confidence in the company's future.

Future Outlook

The vesting of the restricted stock award is contingent upon the director's continued service until August 31, 2025.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The transaction increases the director's alignment with shareholder interests.

Key Dates

Keywords

Onconetix, Thomas Meier, Director, Stock Award, Beneficial Ownership, Form 4, Equity Incentive Plan, Restricted Stock